Skip to main content
Joyce Slingerland, MD, Oncology, Miami, FL

JoyceMSlingerlandMD

Oncology Miami, FL

Professor, Medicine, University of Miami School of Medicine

Dr. Slingerland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Slingerland's full profile

Already have an account?

  • Office

    1611 NW 12th Ave
    Box 016960 M851
    Miami, FL 33136
    Phone+1 305-585-1111
    Fax+1 305-243-9927

Education & Training

  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 1983

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2021 - 2024
  • FL State Medical License
    FL State Medical License 2002 - 2022
  • OH State Medical License
    OH State Medical License 2016 - 2018
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2002
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Breast Cancer Is Increasingly Being Linked to Obesity
    Breast Cancer Is Increasingly Being Linked to ObesityOctober 13th, 2018
  • They Were Thought to Be ‘Too Young’ to Have Breast Cancer. They Were Wrong
    They Were Thought to Be ‘Too Young’ to Have Breast Cancer. They Were WrongOctober 12th, 2018
  • Polycomb Complexes Associate with Enhancers and Promote Oncogenic Transcriptional Programs in Cancer Through Multiple Mechanisms
    Polycomb Complexes Associate with Enhancers and Promote Oncogenic Transcriptional Programs in Cancer Through Multiple MechanismsAugust 23rd, 2018
  • Join now to see all

Grant Support

  • Effects Of The PI3K Pathway On P27 Function And Cancer ProgressionNational Cancer Institute2010–2012
  • Mechanisms Whereby SRC Activates Estrogen Stimulated ER Proteolysis And ER TargetNational Cancer Institute2009–2012
  • Training In Translational Breast Cancer ResearchNational Cancer Institute2007–2011
  • A Neoadjuvant Trial Of Anastrazole And A Novel SRC Inhibitor, Azd0530, For LabcNational Cancer Institute2009–2010
  • PI3K Opposes P27 And G1 Arrest By Tgf-B In Human CancerNational Cancer Institute2004–2007

Professional Memberships